DNA X, Inc.
SONM
$3.94
-$0.54-12.07%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 44.13M | 59.11M | 57.92M | 58.24M | 58.30M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 44.13M | 59.11M | 57.92M | 58.24M | 58.30M |
| Cost of Revenue | 33.11M | 33.11M | 29.50M | 30.92M | 36.43M |
| Gross Profit | 11.02M | 11.02M | 13.43M | 12.34M | 6.89M |
| SG&A Expenses | 5.41M | 4.77M | 5.05M | 4.04M | 3.10M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.41M | 2.44M | -353.00K | -289.00K | 3.10M |
| Operating Income | -5.41M | -1.63M | -28.00K | 234.00K | -3.10M |
| Income Before Tax | -7.96M | -2.54M | -269.00K | 488.00K | -2.88M |
| Income Tax Expenses | 361.00K | 361.00K | 388.00K | 286.00K | 279.00K |
| Earnings from Continuing Operations | -7.96 | -2.62 | -0.38 | 0.48 | -2.88 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -20.66M | -33.38M | -31.14M | -30.28M | -33.65M |
| EBIT | -5.41M | -1.63M | -28.00K | 234.00K | -3.10M |
| EBITDA | -1.11M | 2.09M | 3.66M | 3.97M | 457.00K |
| EPS Basic | -27.01 | -99.43 | -103.93 | -115.20 | -128.40 |
| Normalized Basic EPS | -5.03 | 11.72 | 9.12 | 1.30 | -6.89 |
| EPS Diluted | -27.08 | -99.51 | -104.00 | -115.20 | -128.40 |
| Normalized Diluted EPS | -5.04 | 11.71 | 9.12 | 1.29 | -6.89 |
| Average Basic Shares Outstanding | 2.56M | 2.10M | 1.38M | 1.12M | 1.04M |
| Average Diluted Shares Outstanding | 2.56M | 2.10M | 1.39M | 1.12M | 1.04M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |